Principal Scientist, Omics - R&D Data Science & Digital Health – Neuroscience

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:

Data Analytics & Computational Sciences

Job Sub Function:

Data Science

Job Category:

Scientific/Technology

All Job Posting Locations:

Cambridge, Massachusetts, United States of America, San Diego, California, United States of America, Spring House, Pennsylvania, United States of America

Job Description:

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

Johnson & Johnson Innovative Medicine is recruiting for a Principal Scientist, Omics - R&D Data Science & Digital Health to focus on Neurodegeneration and/or Neuropsychiatry. This position can be located in either Cambridge, MA; Spring House, PA; San Diego, CA, United States of America; or Beerse, Antwerp, Belgium, and may require approximately 10% domestic and international travel.

Please note that this role is available across multiple countries and may be posted under different requisition numbers to align with local requirements.

While you are welcome to apply to any or all of the postings, we recommend focusing on the specific country(s) that align with your preferred location(s):

USA – Requisition Number:  R-052120
Belgium - Requisition Number: R-053690

Role Summary

Our Neuroscience Data Science & Digital Health (DSDH) team integrates the power of multi-omics, digital health technologies and clinical/real-world evidence (RWE) data to accelerate the delivery of transformational therapies for Neurodegeneration, Neuropsychiatry and Ophthalmology. We drive decision-making and breakthroughs from molecular discovery to clinical trials by partnering along the pipeline to ensure that data science & digital health strategies are embedded in every program.

We are seeking a Principal Scientist, Omics to join our DSDH team focused on Neurodegeneration and/or Neuropsychiatry. In this role, you will drive the precision neuroscience strategy by shaping and leading the execution of projects that bring to bear bioinformatics, artificial intelligence and machine learning as needed to link molecular signatures (genetics, gene expression, proteomics) to disease stage and progression, mechanisms of action, and disease endophenotypes. You will be part of a cross-functional team of data science leaders and partner closely with the Neuroscience Therapeutic Area, Quantitative Sciences, and Discovery Product Development and Supply (DPDS).

This position offers the opportunity to transform how we understand disease biology, identify novel targets, stratify patients, and deliver better outcomes for people living with neurodegenerative and neuropsychiatric disorders.

Key Responsibilities

• Shape the strategy and implement projects for data-driven identification and evaluation of novel therapeutic targets, patient stratification approaches and precision biomarkers from the perspective of omics data, brain biology, and mechanism of action, drawing upon a combination of internal and external resources.
• Work in multi-disciplinary teams, composed of discovery scientists, clinicians, computational biologists and biomarker experts to develop precision neuroscience plans across the Neurodegeneration and Neuropsychiatry portfolio, being forward looking and foreseeing a path to launch.
• Remain current on the constantly evolving landscape of neuroscience, neuropsychiatry, and neurodegeneration, omics, bioinformatics and AI/ML research in search of better strategies for accelerating and prioritizing our portfolio based on biological insights.
• Build strong relationships with internal partners and key academic collabo